RCM

RA Capital Management Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$8.67B
AUM Growth
+$1.11B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
87
New
Increased
Reduced
Closed

Top Buys

1
+$177M
2
+$152M
3
+$55.5M
4
BIOA
BioAge Labs
BIOA
+$46M
5
IDYA icon
IDEAYA Biosciences
IDYA
+$42.7M

Top Sells

1
+$88.9M
2
+$75.5M
3
+$63.2M
4
ASND icon
Ascendis Pharma
ASND
+$59.4M
5
URGN icon
UroGen Pharma
URGN
+$51.7M

Sector Composition

1 Healthcare 99.89%
2 Financials 0.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$1.45B 16.72%
9,710,428
-397,972
2
$993M 11.45%
8,689,190
+485,436
3
$416M 4.8%
9,165,652
4
$366M 4.22%
7,506,934
5
$319M 3.68%
6,084,412
6
$289M 3.34%
6,300,408
+900,000
7
$245M 2.82%
10,416,609
8
$241M 2.78%
8,514,862
9
$238M 2.74%
8,909,091
10
$230M 2.65%
1,184,456
+202,317
11
$229M 2.64%
6,381,144
+331,940
12
$194M 2.23%
3,916,825
+222,000
13
$177M 2.04%
+6,955,993
14
$160M 1.84%
31,419,267
15
$157M 1.82%
10,860,977
16
$155M 1.78%
1,851,479
+247,465
17
$152M 1.76%
+9,853,302
18
$149M 1.72%
18,202,009
19
$147M 1.69%
32,285,755
-13,916,670
20
$144M 1.66%
5,009,653
-2,622,993
21
$134M 1.54%
8,064,000
22
$115M 1.33%
1,961,863
23
$110M 1.26%
7,871,721
24
$105M 1.21%
14,175,398
25
$101M 1.17%
15,384,615
1
2 3 4